BIOCURE TECHNOLOGY INC. (1WH) — Working Capital to Net Assets Ratio
BIOCURE TECHNOLOGY INC. (1WH) has a Working Capital to Net Assets ratio of -24.7% as of December 2025. Working capital of €-389.54K (current assets of €45.47K minus current liabilities of €435.01K) is measured against net assets of €1.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See BIOCURE TECHNOLOGY INC. balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BIOCURE TECHNOLOGY INC. Working Capital to Net Assets (2021–2025)
This chart shows how BIOCURE TECHNOLOGY INC.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at -24.7%, reflecting working capital of €-389.54K against net assets of €1.58 Million EUR. Check how tangible is BIOCURE TECHNOLOGY INC.'s equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for BIOCURE TECHNOLOGY INC. (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for BIOCURE TECHNOLOGY INC. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 1WH company net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -24.7% | €-389.54K | €1.58 Million | €45.47K | €435.01K | ▲ +18.2 pp |
| 2024 | -42.9% | €-575.21K | €1.34 Million | €25.77K | €600.97K | ▼ -22.9 pp |
| 2023 | -20.0% | €-320.46K | €1.60 Million | €10.91K | €331.37K | ▼ -204.4 pp |
| 2022 | 184.4% | €-4.29 Million | €-2.33 Million | €118.12K | €4.41 Million | ▼ -5.4 pp |
| 2021 | 189.8% | €-1.62 Million | €-852.32K | €2.13 Million | €3.75 Million | — |